Drawing for QIAGEN SAMPLE & ASSAY TECHNOLOGIES

USPTO serial 79034146

QIAGEN SAMPLE & ASSAY TECHNOLOGIES

Reviewed by CopyMark Law Group

Reg. 3423104Status 709
Filing date
Status date
Registration date
May 6, 2008
Examiner
SOBRAL, CHRISTINA
Law office
GENERIC WEB UPDATE

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with QIAGEN SAMPLE & ASSAY TECHNOLOGIES?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Roxana A. Sullivan

Roxana A. Sullivan Dennemeyer & Associates, LLC120 South LaSalle StreetSuite 1400CHICAGO, IL 60603

Goods and services

ClassDescriptionStatusFirst use
001Chemical, biochemical and biotechnological products for industrial and scientific purposes, namely, sample preparation, purification, lysis, modification and manipulation of cells and marking, separation, isolation, purification, amplification and analysis of biopolymers, namely, nucleic acids; enzymes containing carbon; DNA and RNA polymerases; reagents for staining and marking nucleic acids, peptides and proteins for genetic research; buffer chemicals used in chemistry, biology, biochemistry and biotechnology; aqueous and nonaqueous solutions of primary, secondary and tertiary alcohols and salts for lysis and binding of biological materials; distilled and purified water; silica powder, granulate and gel; magnetic particles, proteins, macro molecules and biologically active substances for separation, analysis and purification of biological and biochemical compounds; materials for separation columns for separation, analysis and purification of biological and biochemical compounds; Chemicals and biochemicals for industrial and scientific purposes, namely, reagents and solvents for sample preparation, purification, lysis, modification and manipulation of cells; Chemicals and biochemicals for industrial and scientific purposes, namely, reagents and solvents for marking, separation, isolation, purification, amplification and analysis of biopolymers; Kits containing chemical, biochemical and biotechnological products for industrial and scientific purposes, namely, for sample preparation, purification, lysis, modification and manipulation of cells and marking, separation, isolation, purification, amplification and analysis of biopolymers, namely, nucleic acids, enzymes containing carbon; DNA and RNA polymerases, reagents for staining and marking acids, peptides and proteins for genetic research, buffer chemicals used in chemistry, biology, biochemistry and biotechnology, aqueous or nonaqueous solutions of primary, secondary and tertiary alcohols and salts for lysis and binding of biological materials, distilled and purified water, silica powder, granulate and gel, magnetic particles, proteins, macro molecules and biologically active substances for separation, analysis and purification of biological or biochemical compounds, materials for separation columns for separation, analysis and purification of biological and biochemical compounds; Chemicals and biochemicals for industrial and scientific purposes, namely, reagents and solvents for sample preparation, purification, lysis, modification and manipulation of cells, reagents and solvents for marking, separation, isolation, purification, amplification and analysis of biopolymers, all included in this classSECTION 71 - CANCELLED—
005Diagnostic preparations for medical and veterinary medical purposes; diagnostic preparations for medical and veterinary medical purposes comprising any of nucleic acids; enzymes; polymerases; reagents for staining and marking; buffer chemicals; aqueous and nonaqueous solutions of primary, secondary and tertiary alcohols and salts; distilled and purified water; silica powder, granulate and gel; magnetic particles; materials for separation columns for separation, analysis and purification of biological and biochemical compounds; and, kits containing all of the preceding named products for medical and veterinary medical purposes, all included in this classSECTION 71 - CANCELLED—
009Scientific apparatus, instruments and equipment for research, development and examination purposes, namely, laboratory equipment, namely, chromatography columns, robots and automated laboratory equipment; spare parts and add-ons therefor; preprogrammed cards for DNA purification protocols; crystallization tubes; prefilled crystallization tubes; microplates and prefilled microplates; crystallization supports; pipettes, pipette tips and pipette tip holders; sample containers; reagent holders; flasks; reagent tube holders; holders for micro containers; magnetic particles and magnetic syringes; biochips; thermocyclers; homogenizers; vacuum valves, all included in this classSECTION 71 - CANCELLED—
042Scientific research, development and diagnostics for others in the fields of chemistry, genetics, biology and biochemistry; diagnostic services for others in the fields of DNA, RNA and protein detection and analysis; services in the field of forensics, namely, analysis, detection and isolation of biological substances in forensic samples; design for others in the fields of chemistry, genetics, biology and biochemistry, all included in this classSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 9, 2022INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Nov 30, 2021INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Nov 30, 2021INPCINVALIDATION PROCESSED—
Oct 26, 2021INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Feb 26, 2021C71TCANCELLED SECTION 71—
May 6, 2017REM4COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED—
Oct 27, 2016RNWLINTERNATIONAL REGISTRATION RENEWED—
May 9, 2014NA75NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED—
May 9, 2014C75AREGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.—
May 9, 2014APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Apr 8, 2014715FREGISTERED - SEC. 71 & SEC. 15 FILED—
Apr 8, 2014ES75TEAS SECTION 71 & 15 RECEIVED—
Dec 22, 2012FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jan 14, 2009ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 14, 2009REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Aug 25, 2008FICSFINAL DISPOSITION NOTICE SENT TO IB—
Aug 25, 2008FIMPFINAL DISPOSITION PROCESSED—
Aug 6, 2008FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
May 6, 2008R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 19, 2008PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 30, 2008NPUBNOTICE OF PUBLICATION—
Jan 14, 2008PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jan 14, 2008CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 14, 2008XAECEXAMINER'S AMENDMENT ENTERED—
Jan 14, 2008GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jan 14, 2008GNEAEXAMINERS AMENDMENT E-MAILED—
Jan 14, 2008CNEAEXAMINERS AMENDMENT -WRITTEN—
Jan 10, 2008ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Nov 16, 2007PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Nov 5, 2007PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Oct 22, 2007CORRCORRECTION FROM IB ENTERED - NO REVIEW REQUIRED—
Oct 16, 2007ALIEASSIGNED TO LIE—
Sep 27, 2007CRCVCORRECTION TRANSACTION RECEIVED FROM IB—
Sep 16, 2007CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 12, 2007XAECEXAMINER'S AMENDMENT ENTERED—
Sep 12, 2007GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Sep 12, 2007GNEAEXAMINERS AMENDMENT E-MAILED—
Sep 12, 2007CNEAEXAMINERS AMENDMENT -WRITTEN—
Sep 7, 2007XAECEXAMINER'S AMENDMENT ENTERED—
Sep 7, 2007GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Sep 7, 2007GNEAEXAMINERS AMENDMENT E-MAILED—
Sep 7, 2007CNEAEXAMINERS AMENDMENT -WRITTEN—
Sep 5, 2007TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 5, 2007CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 5, 2007TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 18, 2007ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 18, 2007REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Mar 23, 2007RFNTREFUSAL PROCESSED BY IB—
Mar 5, 2007RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Mar 1, 2007RFRRREFUSAL PROCESSED BY MPU—
Mar 1, 2007RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Feb 28, 2007CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 26, 2007DOCKASSIGNED TO EXAMINER—
Feb 23, 2007NWAPNEW APPLICATION ENTERED—
Feb 22, 2007REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance